These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30155465)

  • 41. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
    Ishii K; Amagai M; Hall RP; Hashimoto T; Takayanagi A; Gamou S; Shimizu N; Nishikawa T
    J Immunol; 1997 Aug; 159(4):2010-7. PubMed ID: 9257868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity.
    Koopai M; Mortazavi H; Khatami A; Khodashenas Z
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.
    Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M
    J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression.
    Abidi NY; Lainiotis I; Malikowski G; Seiffert-Sinha K; Sinha AA
    J Drugs Dermatol; 2017 Feb; 16(2):135-139. PubMed ID: 28300855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding of pemphigus vulgaris IgG to antigens in desmosome core domains excludes immune complexes rather than directly splitting desmosomes.
    Aoyama Y; Nagai M; Kitajima Y
    Br J Dermatol; 2010 May; 162(5):1049-55. PubMed ID: 20222919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous immunolocalization of desmoglein 3 and IgG4 in oral pemphigus vulgaris: IgG4 predominant autoantibodies in its pathogenesis.
    Abé T; Maruyama S; Babkair H; Yamazaki M; Cheng J; Saku T
    J Oral Pathol Med; 2015 Nov; 44(10):850-6. PubMed ID: 25401705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nuclear magnetic resonance titration of the interaction between pemphigus vulgaris autoantibodies and REWVKFAKPCRE, a therapeutic desmoglein 3 peptide.
    Lucchese A; Sinha AA
    Clin Exp Dermatol; 2016 Aug; 41(6):585-90. PubMed ID: 26936204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
    Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utility of desmoglein ELISA in the clinical correlation and disease monitoring of pemphigus vulgaris.
    Anand V; Khandpur S; Sharma VK; Sharma A
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1377-83. PubMed ID: 21981406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
    Sharma VK; Prasad HR; Khandpur S; Kumar A
    Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances in the study of the pathophysiology of pemphigus.
    Hashimoto T
    Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S2-11. PubMed ID: 12677426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris.
    Müller R; Svoboda V; Wenzel E; Gebert S; Hunzelmann N; Müller HH; Hertl M
    Exp Dermatol; 2006 Aug; 15(8):606-14. PubMed ID: 16842599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
    Hashimoto T; Amagai M; Garrod DR; Nishikawa T
    Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins.
    Sekiguchi M; Futei Y; Fujii Y; Iwasaki T; Nishikawa T; Amagai M
    J Immunol; 2001 Nov; 167(9):5439-48. PubMed ID: 11673563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of diagnostic value of indirect immunofluorescence assay and desmoglein ELISA in the diagnosis of pemphigus.
    Marinović B; Fabris Z; Lipozencić J; Stulhofer Buzina D; Lakos Jukić I
    Acta Dermatovenerol Croat; 2010; 18(2):79-83. PubMed ID: 20624356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris.
    Lo AS; Mao X; Mukherjee EM; Ellebrecht CT; Yu X; Posner MR; Payne AS; Cavacini LA
    PLoS One; 2016; 11(6):e0156800. PubMed ID: 27304671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
    Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
    Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus.
    Futei Y; Amagai M; Ishii K; Kuroda-Kinoshita K; Ohya K; Nishikawa T
    J Dermatol Sci; 2001 May; 26(1):55-61. PubMed ID: 11323221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.